17 January 2024 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce it has received Medical Device Marketing Authorization (MDMA) from the Saudi Food & Drug Authority (SFDA). MDMA clears the way for Imricor to begin commercialization efforts in the Kingdom of Saudi … Read More
Maastricht University Medical Center Signs Purchase Agreement with Imricor
29 September 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided ablation products, is pleased to announce the Maastricht University Medical Centre (MUMC) in the Netherlands has signed a purchase agreement for Imricor’s consumable products.
Imricor Signs Agreement with German Group Purchasing Organisation, Sana
Imricor Medical Systems, Inc. is pleased to announce that it has signed a Master Purchasing Agreement with Sana Einkauf & Logistik GmbH of Ismaning Germany (Sana). Sana is the largest Group Purchasing Organisation (GPO) in Germany, with 600 cooperating hospitals and medical institutions across Germany and Switzerland. Approximately 80 of these sites perform cardiac ablations and are therefore potential Imricor customers.